Stockscreener 앱 받기
0.3122
4.26%
-0.0139
시간 외 거래:
.33
0.0178
+5.70%
전일 마감가:
$0.3261
열려 있는:
$0.3399
하루 거래량:
371.60K
Relative Volume:
0.17
시가총액:
$12.97M
수익:
$62.71M
순이익/손실:
$-10.48M
주가수익비율:
-0.4956
EPS:
-0.63
순현금흐름:
$-13.77M
1주 성능:
-4.26%
1개월 성능:
-28.06%
6개월 성능:
+19.80%
1년 성능:
-87.71%
1일 변동 폭
$0.305
$0.3399
1주일 범위
$0.303
$0.3489
52주 변동 폭
$0.2179
$3.00
프로페이즈 Stock (PRPH) Company Profile
명칭
Prophase Labs Inc
전화
(215) 345-0919
주소
711 STEWART AVE, SUITE 200, NEW YORK, PA
PRPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.3122 | 13.15M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
프로페이즈 Stock (PRPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-20 | 개시 | H.C. Wainwright | Buy |
| 2021-10-13 | 다운그레이드 | Dawson James | Buy → Neutral |
| 2021-01-20 | 개시 | Dawson James | Buy |
프로페이즈 주식(PRPH)의 최신 뉴스
Is ProPhase Labs Inc. vulnerable to short sellersElite Return Strategy Watch - thegnnews.com
ProPhase Labs Inc. Bounces Off Moving Average SupportLow Drawdown Real Time Trading Tips Shared - beatles.ru
ProPhase Labs Appoints New Fractional CFO - TipRanks
Sector ETF Data Correlates with Strength in ProPhase Labs Inc.Low Volatility Stable Growth Picks Rank High - metal.it
Is This a Bottoming Phase for ProPhase Labs Inc.Confirmed Setup With Expert Accuracy Supported - beatles.ru
ProPhase Labs Inc. Rebound Backed by Sentiment ShiftInvestment Plan With Growth Optimization Finalized - metal.it
Why is ProPhase Labs Inc. stock attracting strong analyst attentionBreakneck growth rates - Jammu Links News
How does ProPhase Labs Inc. generate profit in a changing economyExceptional trading performance - Jammu Links News
Is ProPhase Labs Inc. a growth stock or a value stockMaximize your portfolio’s earning power - Jammu Links News
What makes ProPhase Labs Inc. stock price move sharplyHigh-yield trading alerts - Jammu Links News
Is ProPhase Labs Inc. a good long term investmentTrack high-yield stocks before they peak - Jammu Links News
What institutional investors are buying ProPhase Labs Inc. stockInvest confidently with data-driven strategies - Jammu Links News
Should I hold or sell ProPhase Labs Inc. stock in 2025Consistently profitable trades - Jammu Links News
How volatile is ProPhase Labs Inc. stock compared to the marketBuild a diversified portfolio for risk management - Jammu Links News
What drives ProPhase Labs Inc. stock priceOver 200% growth - Jammu Links News
What are analysts’ price targets for ProPhase Labs Inc. in the next 12 monthsBuild a winning investment strategy - Jammu Links News
How does ProPhase Labs Inc. compare to its industry peersExceptional earning trajectories - Jammu Links News
What catalysts could drive ProPhase Labs Inc. stock higher in 2025Market Forecast Updates That Work - Jammu Links News
What are ProPhase Labs Inc. company’s key revenue driversAI Powered Forecasts With Proven Results - jammulinksnews.com
ProPhase Labs Announces Shareholder Meeting to Increase Authorized Shares to 1 Billion, Targets $50 Million Covid Accounts Receivables Collection, and Advances BE-Smart Esophageal Cancer Test Development. - AInvest
Screener Results Flag ProPhase Labs Inc. as OversoldSmart Allocation Stock Pick Insights Gaining Interest - metal.it
Why ProPhase Labs Inc. stock attracts strong analyst attentionEntry Alert With Low Drawdown Strategy Noted - beatles.ru
ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement - GlobeNewswire
ProPhase Labs Inc. Stock Flags Risk Zone in Volatility IndexEarly Entry Picks Before News Breakout Reviewed - metal.it
ProPhase Labs (PRPH) Seeks Shareholder Approval to Expand Share Authorization - GuruFocus
Prophase Labs Files Proxy to Increase Shares - TipRanks
ProPhase Labs Seeks 1 Billion Share Authorization to Transform from Biotech to Crypto Treasury Player - Stock Titan
Will ProPhase Labs Inc. benefit from macro trendsFree Capital Preserving Trade Plan Templates - Newser
Published on: 2025-07-29 09:36:25 - metal.it
Will ProPhase Labs Inc. stock recover after recent dropDeep Learning Stock Forecast for Investors - Newser
Price Consolidation Hints at Upcoming Move in ProPhase Labs Inc.Stock Market Entry Timing Signals Revealed - beatles.ru
Prophase Labs Secures $3M Investment Through Private Placement to Protect Shareholder Value and Fund Operations. - AInvest
What is the dividend policy of ProPhase Labs Inc. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com
Prophase Labs Secures $3M Investment Through Private Placement - TipRanks
What earnings revisions data tells us about ProPhase Labs Inc.Momentum Screener with Buy and Sell Areas - Newser
Published on: 2025-07-28 05:29:42 - Newser
Regression analysis insights on ProPhase Labs Inc. performance Free Buy Alerts With Low Risk Confirmation - Newser
What makes ProPhase Labs Inc. stock price move sharply Daily Stock Forecast Powered by AI Tools - Newser
When is ProPhase Labs Inc. stock expected to show significant growthPowerful profit generation - jammulinksnews.com
What are the technical indicators suggesting about ProPhase Labs Inc.Get daily updates on market movers and shakers - Jammu Links News
프로페이즈 (PRPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
자본화:
|
볼륨(24시간):